Document Detail

An In Vitro Diagnostic Multivariate Index Assay (IVDMIA) for Ovarian Cancer: Harvesting the Power of Multiple Biomarkers.
MedLine Citation:
PMID:  22582125     Owner:  NLM     Status:  PubMed-not-MEDLINE    
In this review, OVA1® (Vermillion, Inc., Austin, TX), the first in vitro diagnostic multivariate index assay (IVDMIA) of protein biomarkers cleared by the US Food and Drug Administration (FDA), is used to explain the concept behind IVDMIA, the use of multiple markers to improve clinical performance of a diagnostic tool, and the key considerations in the development of IVDMIA.
Zhen Zhang
Related Documents :
6689335 - Comparison of bioavailability for phenytoin products prepared by wet granulation in nor...
20492195 - Bioavailability and delivery of nutraceuticals using nanotechnology.
8929745 - Pharmacokinetics of thiamine derivatives especially of benfotiamine.
19533365 - Body mass index, neighborhood fast food and restaurant concentration, and car ownership.
17490715 - Approaches to assess the oral bioaccessibility of persistent organic pollutants: a crit...
17706395 - Laccase production at reactor scale by filamentous fungi.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Reviews in obstetrics & gynecology     Volume:  5     ISSN:  2153-8166     ISO Abbreviation:  Rev Obstet Gynecol     Publication Date:  2012  
Date Detail:
Created Date:  2012-05-14     Completed Date:  2012-10-02     Revised Date:  2014-08-28    
Medline Journal Info:
Nlm Unique ID:  101479674     Medline TA:  Rev Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  35-41     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comprehensive surgical staging for endometrial cancer.
Next Document:  Genetic testing for lynch syndrome, an inherited cancer of the bowel, endometrium, and ovary.